Search research articles
Contact Us
Filters
Showing results (141-150 of 750) with videos related to
Page
of 75
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 18, 2020
Prevalence of Fatty Liver Disease and Fibrosis Detected by Transient Elastography in Adults in the United States, 2017-2018
Donghee Kim, George Cholankeril, Rohit Loomba, et al.
Hepatology (Baltimore, Md.)
|
March 30, 2026
Noninvasive surrogate endpoints of adverse outcomes, disease progression, and treatment efficacy in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Arun J Sanyal, Manal F Abdelmalek, Rohit Loomba
Current Diabetes Reports
|
March 14, 2026
Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes
Konstantinos Malandris, Konstantinos Charalampidis, Rohit Loomba, et al.
The New England Journal of Medicine
|
October 16, 2024
Two Trials of Therapeutics for MASH with Liver Fibrosis. Reply
Rohit Loomba, Mark L Hartman, Arun J Sanyal
Journal of Cardiovascular Development and Disease
|
February 9, 2018
Is an Appreciation of Isomerism the Key to Unlocking the Mysteries of the Cardiac Findings in Heterotaxy?
Robert H Anderson, Diane E Spicer, Rohit Loomba
Hepatology Communications
|
September 9, 2021
What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond?
Naim Alkhouri, Monica Tincopa, Rohit Loomba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 12, 2021
Treatment Candidacy for Pharmacologic Therapies for NASH
Ian A Rowe, Vincent Wai-Sun Wong, Rohit Loomba
Journal of Hepatology
|
April 15, 2023
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Frank Tacke, Tobias Puengel, Rohit Loomba, et al.
Journal of Lipid Research
|
November 19, 2014
Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis
Rohit Loomba, Oswald Quehenberger, Aaron Armando, et al.
Alimentary Pharmacology & Therapeutics
|
May 14, 2025
Review Article: GLP-1 Receptor Agonists and Glucagon/GIP/GLP-1 Receptor Dual or Triple Agonists-Mechanism of Action and Emerging Therapeutic Landscape in MASLD
Maryam Zafer, Federica Tavaglione, Manuel Romero-Gómez, et al.
Page
of 75
Search research articles
Search
Showing results (141-150 of 750) with videos related to
Sort By:
Page
of 75
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 18, 2020
Prevalence of Fatty Liver Disease and Fibrosis Detected by Transient Elastography in Adults in the United States, 2017-2018
Donghee Kim, George Cholankeril, Rohit Loomba, et al.
Hepatology (Baltimore, Md.)
|
March 30, 2026
Noninvasive surrogate endpoints of adverse outcomes, disease progression, and treatment efficacy in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Arun J Sanyal, Manal F Abdelmalek, Rohit Loomba
Current Diabetes Reports
|
March 14, 2026
Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes
Konstantinos Malandris, Konstantinos Charalampidis, Rohit Loomba, et al.
The New England Journal of Medicine
|
October 16, 2024
Two Trials of Therapeutics for MASH with Liver Fibrosis. Reply
Rohit Loomba, Mark L Hartman, Arun J Sanyal
Journal of Cardiovascular Development and Disease
|
February 9, 2018
Is an Appreciation of Isomerism the Key to Unlocking the Mysteries of the Cardiac Findings in Heterotaxy?
Robert H Anderson, Diane E Spicer, Rohit Loomba
Hepatology Communications
|
September 9, 2021
What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond?
Naim Alkhouri, Monica Tincopa, Rohit Loomba, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 12, 2021
Treatment Candidacy for Pharmacologic Therapies for NASH
Ian A Rowe, Vincent Wai-Sun Wong, Rohit Loomba
Journal of Hepatology
|
April 15, 2023
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
Frank Tacke, Tobias Puengel, Rohit Loomba, et al.
Journal of Lipid Research
|
November 19, 2014
Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis
Rohit Loomba, Oswald Quehenberger, Aaron Armando, et al.
Alimentary Pharmacology & Therapeutics
|
May 14, 2025
Review Article: GLP-1 Receptor Agonists and Glucagon/GIP/GLP-1 Receptor Dual or Triple Agonists-Mechanism of Action and Emerging Therapeutic Landscape in MASLD
Maryam Zafer, Federica Tavaglione, Manuel Romero-Gómez, et al.
Page
of 75